𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Improved Renal Function After Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation

✍ Scribed by L. Mjörnstedt; S. S. Sørensen; B. von zur Mühlen; B. Jespersen; J. M. Hansen; C. Bistrup; H. Andersson; B. Gustafsson; L.H. Undset; H. Fagertun; D. Solbu; H. Holdaas

Book ID
114806514
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
640 KB
Volume
12
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conversion from a calcineurin inhibitor
Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial
✍ Paolo De Simone; Herold J. Metselaar; Lutz Fischer; Jérôme Dumortier; Karim Boud 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

Calcineurin inhibitors (CNIs) contribute to renal dysfunction following liver transplantation. This prospective, randomized, multicenter, 6-month study (with an additional 6 months of follow-up) evaluated whether everolimus with CNI reduction or discontinuation would improve renal function in mainte

Improvement of renal function after the
Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction
✍ Javier F. Castroagudín; Esther Molina; Rafael Romero; Esteban Otero; Santiago To 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro